BIO Welcomes Advances in Stem Cell Research
Washington 08 August 2008  BIO President and CEO Jim Greenwood issued the following statement regarding the news that researchers at the Harvard Stem Cell Institute created 20 disease-specific stem cell lines thru the new induced pluripotent stem cell (iPS) technique.
---------------------------------------------------------------------------------------------------------
Putting microRNAs on the stem cell map
Cambridge 07 August 2008  Embryonic stem cells are always facing a choice either to self-renew or begin morphing into another type of cell altogether.It’s a tricky choice, governed by complex gene regulatory circuitry driven by a handful of key regulators known as “master transcription factors,” proteins that switch gene expression on or off.
---------------------------------------------------------------------------------------------------------
Daley and colleagues create 20 disease-specific stem cell lines
Cambridge 07 August 2008  Harvard Stem Cell Institute researcher George Q. Daley, associate director of the Stem Cell Program at Children's Hospital Boston, has with HSCI colleagues Chad Cowan and Konrad Hochedlinger of Massachusetts General Hospital produced a robust new collection of disease-specific stem cell lines, all of which were developed using the new induced pluripotent stem cell (iPS) technique. The work is described in a paper published in today's online edition of the journal Cell.
---------------------------------------------------------------------------------------------------------
U.S. FDA Authorizes IND Application for Aastrom's First Cardiac Regeneration Clinical Trial
Ann Arbor, Michigan, U.S.A 23 June 2008  Aastrom to Initiate Phase II Clinical Trial Using Cardiac Repair Cells Derived From Patient's Own Bone Marrow for Treatment of Severe Chronic Heart Failure
---------------------------------------------------------------------------------------------------------
Stem Cell Activation Discovery Holds Promise For Lung Tissue Repair
Philadelphia, Pennsylvania, U.S.A 23 June 2008  Activation of a molecular pathway important in stem cell and developmental biology leads to an increase in lung stem cells, according to researchers from the University of Pennsylvania School of Medicine, and harnessing this knowledge could help develop therapies for lung-tissue repair after injury or disease.
---------------------------------------------------------------------------------------------------------
<< Previous 1 2 3 4 5 6 7 Next >> |
